Page last updated: 2024-11-01

omeprazole and Axonotmesis

omeprazole has been researched along with Axonotmesis in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Neuropathic pain is well known to occur after damage to the somatosensory system."1.72Modulation of Aryl Hydrocarbon Receptor Expression Alleviated Neuropathic Pain in a Chronic Constriction Nerve Injury Animal Model. ( Pan, HC; Pan, LY; Sheehan, J; Sheu, ML; Yang, MY, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sheu, ML1
Pan, LY1
Sheehan, J1
Yang, MY1
Pan, HC1

Other Studies

1 other study available for omeprazole and Axonotmesis

ArticleYear
Modulation of Aryl Hydrocarbon Receptor Expression Alleviated Neuropathic Pain in a Chronic Constriction Nerve Injury Animal Model.
    International journal of molecular sciences, 2022, Sep-24, Volume: 23, Issue:19

    Topics: Animals; Constriction; Constriction, Pathologic; Crush Injuries; Disease Models, Animal; Hyperalgesi

2022